NASDAQ:VKTX

Viking Therapeutics Stock News

etoro logo Buy VKTX
*Your capital is at risk
$32.37
+1.99 (+6.55%)
At Close: Jun 22, 2026
Hims & Hers has a booming telemedicine business that could grow by 57% this year. Viking Therapeutics has a promising pipeline that features a couple of potential blockbuster drugs.

The 3 Best Momentum Stocks to Buy in July

06:32pm, Friday, 07'th Jul 2023
Momentum stocks offer investors the opportunity to capitalize on strong and continued upward price changes. At the same time, it is an inherently and undeniably risky trading method.
Now is a great time to accumulate top undervalued biotech stocks. For one, the sector is recession-proof.
Viking and Nano-X are up-and-comers in healthcare with exciting products in the works. However, neither business is profitable, and it could be years before either one is.

Why Viking Therapeutics Is Plunging Today

01:53pm, Tuesday, 27'th Jun 2023
After positive mid-stage data, Eli Lilly seems to have a chance at achieving best-in-class status in the valuable weight loss market. Viking's shares are sinking in response to this development.

Factbox: Weight-loss drugs: the next gold rush

10:56am, Tuesday, 27'th Jun 2023
Drug developers are chasing an obesity drug gold rush that may be worth up to $100 billion by rolling out treatments that can help lose as much as 24% of weight in less than a year.
A top competitor announced plans to move forward with a late-stage weight loss candidate today. Viking's weight-loss candidate is several years behind from a development standpoint.
With patent expirations around the corner, some of the biggest pharmaceutical and biotech companies will soon face generic competition, creating a big opportunity for these top biotech stocks to buy.
Investing in healthcare stocks can be a wise decision for those looking to become wealthy in the long term. Some of the best healthcare stocks to buy are firms that are developing highly effective dr
Alibaba has tremendous growth opportunities in AI. Intellia Therapeutics' gene-editing therapies hold the potential to be big winners.
Nano-X is marketing a different type of X-ray system. DermTech's Smart Sticker system could change dermatology.
Viking Therapeutics has a few drugs that have the potential to generate billions in revenue. The problem is that they are in early-stage trials, so there's ample uncertainty with the business.
Amylyx Pharmaceuticals and Viking Therapeutics have been on fire over the past year. Even so, both companies still look incredibly undervalued relative to their long-term growth potential.
Novo Nordisk's medicines for obesity and diabetes are spawning many copycats. Viking Therapeutics' stock is soaring thanks to its favorable early results.
Viking Therapeutics is a biotech with multiple potential blockbuster drugs in its portfolio. Encouraging trial results have made investors bullish about the stock's prospects.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE